Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
24.19
-1.29 (-5.06%)
At close: Sep 12, 2025, 4:00 PM EDT
24.22
+0.03 (0.12%)
After-hours: Sep 12, 2025, 7:00 PM EDT
Phreesia Market Cap
Phreesia has a market cap or net worth of $1.45 billion as of September 12, 2025. Its market cap has decreased by -0.27% in one year.
Market Cap
1.45B
Enterprise Value
1.36B
1-Year Change
-0.27%
Ranking
Category
Stock Price
$24.19
Market Cap Chart
Since July 18, 2019, Phreesia's market cap has increased from $882.45M to $1.45B, an increase of 64.24%. That is a compound annual growth rate of 8.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.45B | -0.89% |
| Dec 31, 2024 | 1.46B | 13.55% |
| Dec 29, 2023 | 1.29B | -24.54% |
| Dec 30, 2022 | 1.71B | -20.04% |
| Dec 31, 2021 | 2.13B | -10.92% |
| Dec 31, 2020 | 2.40B | 150.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |